Roshanak Asgariroozbehani Selected Research

Roshanak Asgariroozbehani Research Topics

4	Schizophrenia (Dementia Praecox) 12/2021 - 01/2020
2	Weight Gain 01/2022 - 01/2021
2	Insulin Resistance 01/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2020
2	Inflammation (Inflammations) 01/2021 - 01/2020
1	Psychotic Disorders (Schizoaffective Disorder) 01/2021
1	Bulimia (Binge Eating) 12/2020
1	Food Addiction 12/2020
1	Body Weight (Weight, Body) 01/2020
1	Cognitive Dysfunction 01/2020

3	Antipsychotic Agents (Antipsychotics)IBA 01/2021 - 12/2020
3	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2020
2	Olanzapine (Zyprexa)FDA Link 01/2022 - 01/2021
2	Insulin (Novolin)FDA Link 01/2020 - 01/2020
1	Quetiapine Fumarate (Seroquel)FDA Link 01/2022
1	Risperidone (Risperdal Consta)FDA LinkGeneric 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	CytokinesIBA 12/2021
1	KATP ChannelsIBA 01/2021
1	Glutamic Acid (Glutamate)FDA Link 01/2020
1	Dopamine (Intropin)FDA LinkGeneric 01/2020

1	Off-Label Use 01/2022
1	Lasers (Laser) 12/2021